Skip to main content
🎂 — | ♂/♀ M/F | ⚖️ — kg | 📏 — cm | BMI — | 👟 —
⚡ 88%
🩺 Chronic Disease Meds

ꯗ꯭ꯔꯒ ꯏꯚꯨꯁꯦꯜꯗ (ꯇꯤꯛꯁꯥꯒꯦꯚꯤꯃꯦꯕ; ꯁꯤꯂꯒꯥꯚꯤꯃꯦꯕ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯉꯂꯁꯤ? ꯃꯁꯤꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯗꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯗꯥ ꯃꯇꯦꯡ ꯑꯣꯏꯔꯤꯕꯔꯥ?

MBBS
Medically Reviewed by MBBS ✓ Medically Reviewed
📅 Updated: Jul 15, 2026 • ⏱ 5 min read • ꯑꯦꯗꯤꯇꯣꯔꯤꯌꯜ ꯄꯣꯂꯤꯁꯤ꯫
ꯗ꯭ꯔꯒ ꯏꯚꯨꯁꯦꯜꯗ (ꯇꯤꯛꯁꯥꯒꯦꯚꯤꯃꯦꯕ; ꯁꯤꯂꯒꯥꯚꯤꯃꯦꯕ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯉꯂꯁꯤ? ꯃꯁꯤꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯗꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯗꯥ ꯃꯇꯦꯡ ꯑꯣꯏꯔꯤꯕꯔꯥ?
Table of Contents ▾

ꯅꯍꯥꯛꯀꯤ ꯏꯃꯨꯡꯗꯥ ꯀꯤꯗꯅꯤ ꯇ꯭ꯔꯥꯟꯁꯞꯂꯥꯟꯇ ꯇꯧꯔꯕꯥ, ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯂꯤꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯑꯍꯜ ꯑꯣꯏꯔꯕꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯥ ꯂꯩꯕ꯭ꯔꯥ? ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ ꯂꯥꯛꯂꯕꯗꯤ ꯃꯈꯣꯌꯗꯥ ꯀꯣꯕꯤꯗ-꯱꯹ ꯍꯦꯟꯅꯥ ꯁꯣꯀꯍꯜꯂꯀꯄꯥ ꯌꯥꯏ? ꯃꯈꯣꯌꯒꯤ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯁꯣꯟꯊꯔꯀꯄꯥ ꯌꯥꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯈꯣꯌꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯒꯤ ꯇꯤꯀꯥ ꯑꯁꯤ ꯐꯖꯅꯥ ꯔꯦꯁ꯭ꯄꯣꯟꯁ ꯇꯧꯗꯕꯥ ꯌꯥꯏ꯫ ꯉꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯃꯈꯣꯌꯒꯨꯝꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡ ꯀꯣꯕꯤꯗ-꯱꯹ꯗꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯕꯥ ꯉꯝꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯅꯔꯤ꯫

⚡ Interactive Clinical Tool
⚖️

BMI Calculator

Know your body mass index (BMI) and weight classification

Open Interactive Calculator →

ꯏꯚꯨꯁꯦꯜꯗ (Tixagevimab; Cilgavimab) ꯀꯧꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯀꯔꯤꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ ꯃꯁꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯅꯥꯔꯀꯄꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯟꯊꯍꯟꯅꯕꯥ ꯄꯤꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯁꯣꯟꯊꯔꯀꯄꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯒꯤ ꯇꯤꯀꯥꯗꯥ ꯐꯖꯅꯥ ꯔꯦꯁ꯭ꯄꯣꯟꯁ ꯇꯧꯗꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛ, ꯅꯠꯔꯒꯥ ꯃꯔꯝ ꯈꯔꯗꯒꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯇꯤꯀꯥ ꯂꯧꯕꯥ ꯉꯃꯗꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯣꯅꯣꯛꯂꯣꯅꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤ ꯀꯧꯕꯥ ꯗ꯭ꯔꯒ ꯀꯥꯡꯂꯨꯞ ꯑꯃꯒꯤ ꯃꯅꯨꯡ ꯆꯜꯂꯤ . ꯈꯟꯊꯕꯤꯌꯨ, ꯑꯩꯈꯣꯌꯒꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯂꯥꯌꯅꯥ ꯂꯥꯟꯊꯦꯡꯅꯅꯕꯥ ‘ꯑꯦꯟꯇꯤꯕꯣꯗꯤ’ ꯀꯧꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡ ꯂꯩ, ꯅꯠꯇꯦ? ꯌꯥꯏ, ꯍꯥꯌꯔꯤꯕꯥ ꯑꯁꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯚꯥꯏꯔꯁ ꯊꯦꯡꯅꯅꯕꯥ ꯑꯈꯟꯅꯅꯥ ꯂꯦꯕꯣꯔꯦꯇꯔꯤꯗꯥ ꯁꯦꯃꯈꯤꯕꯥ ꯑꯥꯔꯇꯤꯐꯤꯁꯤꯑꯦꯜ ꯑꯦꯟꯇꯤꯕꯣꯗꯤꯁꯤꯡꯅꯤ꯫ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯄꯤꯔꯀꯄꯥ ꯃꯇꯃꯗꯥ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯚꯥꯏꯔꯁ ꯑꯁꯤ ꯆꯪꯂꯛꯂꯕꯗꯤ, ꯃꯈꯣꯌꯅꯥ ꯃꯁꯤꯒꯥ ꯂꯥꯟꯊꯦꯡꯅꯔꯤ, ꯃꯁꯤꯅꯥ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯔꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯥꯏꯖꯦꯁꯅꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯟꯊꯍꯜꯂꯤ꯫

ꯃꯔꯨ ꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯃꯁꯤ ꯍꯥꯟꯅꯗꯒꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯅꯥꯔꯕꯥ ꯃꯤꯑꯣꯏ ꯑꯃꯒꯤ ꯂꯥꯏꯌꯦꯡ ꯅꯠꯇꯦ꯫ ꯃꯁꯤ ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯉꯥꯀꯊꯣꯛꯅꯕꯥ ꯄꯤꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ꯫

ꯗ꯭ꯔꯒ ꯑꯁꯤ ꯌꯨꯅꯥꯏꯇꯦꯗ ꯁ꯭ꯇꯦꯇꯁꯇꯥ ꯂꯩꯕꯥ ꯑꯦꯐ.ꯗꯤ.ꯑꯦ.ꯅꯥ ꯑꯦꯃꯔꯖꯦꯟꯁꯤ ꯌꯨꯖ (ꯏꯃꯔꯖꯦꯟꯁꯤ ꯌꯨꯖ ꯑꯣꯊꯣꯔꯥꯏꯖꯦꯁꯟ) ꯐꯥꯑꯣꯕꯥ ꯑꯌꯥꯕꯥ ꯄꯤꯈ꯭ꯔꯦ꯫ ꯃꯁꯤꯅꯥ ꯇꯥꯀꯄꯗꯤ ꯃꯁꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯂꯥꯏꯆꯠꯒꯨꯝꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯐꯤꯚꯃꯁꯤꯡꯗꯥ ꯑꯀꯛꯅꯕꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯌꯥꯍꯅꯈ꯭ꯔꯦ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯅꯍꯥꯛꯀꯤꯗꯃꯛꯇꯥ ꯆꯨꯝꯃꯤ ꯍꯥꯌꯕꯥ ꯋꯥꯔꯦꯞ ꯂꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯄꯨꯡꯐꯥꯕꯥ ꯍꯦꯂꯊ ꯍꯤꯁ꯭ꯇꯔꯤ ꯑꯗꯨ ꯈꯪꯖꯤꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯃꯍꯥꯀꯄꯨ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ:

ꯅꯍꯥꯛꯅꯥ ꯄꯤꯒꯗꯕꯥ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ꯫ ꯃꯗꯨ ꯀꯔꯤꯒꯤ ꯃꯔꯨ ꯑꯣꯏꯔꯤꯕꯅꯣ?
ꯅꯍꯥꯛꯅꯥ ꯂꯩꯕꯥ ꯌꯥꯕꯥ ꯑꯦꯂꯥꯔꯖꯤ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯃꯇꯥꯡꯗꯥ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯅꯠꯠꯔꯒꯥ ꯃꯁꯤꯒꯤ ꯏꯅꯒ꯭ꯔꯦꯗꯤꯌꯦꯟꯇ ꯑꯃꯍꯦꯛꯇꯗꯥ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯥꯀꯄꯒꯤ ꯔꯤꯁ꯭ꯛ ꯑꯗꯨ ꯑꯦꯁꯦꯁ ꯇꯧꯕꯥ꯫
ꯅꯍꯥꯛꯀꯤ ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥꯒꯤ ꯃꯇꯥꯡꯗꯥ . ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯈꯔꯗꯥ ꯁꯣꯀꯍꯅꯕꯥ ꯌꯥꯕꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯔꯤꯁ꯭ꯛ ꯑꯁꯤ ꯑꯦꯁꯦꯁ ꯇꯧꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯏ ꯊꯣꯀꯄꯥ ꯗꯤꯁꯑꯣꯔꯗꯔ ꯑꯃꯥ ꯂꯩꯔꯕꯗꯤ . ꯃꯁꯤ ꯏꯟꯠꯔꯥꯃꯥꯁ꯭ꯀꯨꯂꯥꯔ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯣꯏꯕꯅꯥ ꯃꯔꯝ ꯑꯣꯏꯗꯨꯅꯥ ꯏ ꯊꯣꯀꯄꯥ ꯌꯥꯕꯒꯤ ꯈꯨꯗꯣꯡꯊꯤꯕꯥ ꯂꯩꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯑꯈꯟꯅꯕꯥ ꯆꯦꯀꯁꯤꯟ ꯊꯧꯔꯥꯡ ꯂꯧꯈꯠꯀꯗꯕꯅꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯒꯤ ꯇꯤꯀꯥ ꯑꯃꯥ ꯐꯪꯂꯕꯗꯤ , ꯃꯁꯤꯒꯤ ꯑꯀꯨꯞꯄꯥ ꯃꯔꯣꯂꯁꯤꯡ꯫ ꯃꯁꯤꯒꯤ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯑꯁꯤ ꯃꯔꯨ ꯑꯣꯏꯔꯤ ꯃꯔꯃꯗꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯕꯒꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯒꯤ ꯇꯤꯀꯥ ꯂꯧꯕꯒꯤ ꯃꯔꯛꯇꯥ ꯃꯇꯃꯒꯤ ꯑꯔꯥꯞꯄꯥ ꯂꯩꯒꯗꯕꯅꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯤꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯤ ꯅꯨꯄꯤ ꯑꯃꯥ ꯑꯣꯏꯔꯕꯗꯤ . ꯃꯤꯔꯣꯜꯂꯤꯉꯩ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯁꯦꯐꯇꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯈꯟꯅꯒꯗꯕꯅꯤ꯫
ꯑꯇꯣꯞꯄꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯄꯨꯝꯅꯃꯛꯀꯤ ꯃꯇꯥꯡꯗꯥ , ꯚꯤꯇꯥꯃꯤꯅꯁꯤꯡ, ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯇ꯭ꯔꯦꯗꯤꯁꯅꯦꯜ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯑꯇꯣꯞꯄꯥ ꯍꯤꯗꯥꯀꯁꯤꯡꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯁꯣꯛꯅ-ꯁꯝꯅꯔꯀꯄꯥ ꯌꯥꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯌꯦꯡꯁꯤꯟꯅꯕꯥ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯄꯤꯕꯒꯦ?

ꯃꯁꯤ ꯅꯍꯥꯛꯅꯥ ꯌꯨꯃꯗꯥ ꯄꯨꯔꯀꯄꯥ ꯌꯥꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ ꯂꯩꯕꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯝ ꯑꯃꯅꯥ ꯄꯤꯔꯤ . ꯇꯤꯛꯁꯥꯒꯦꯚꯤꯃꯦꯕ ꯑꯃꯁꯨꯡ ꯁꯤꯂꯒꯥꯚꯤꯃꯦꯕ ꯍꯥꯌꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯅꯤ ꯑꯁꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯃꯁꯜ ꯑꯃꯗꯥ (ꯏꯅꯠꯔꯥꯃꯥꯁ꯭ꯀꯨꯂꯥꯔ ꯑꯣꯏꯅꯥ) ꯃꯇꯝ ꯑꯃꯗꯥ ꯇꯣꯉꯥꯅꯕꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯅꯤ ꯑꯣꯏꯅꯥ ꯄꯤ꯫ ꯃꯍꯧꯁꯥꯅꯥ ꯃꯁꯤꯒꯤꯗꯃꯛꯇꯥ ꯕꯠꯇꯣꯛꯁꯀꯤ ꯃꯁꯂꯁꯤꯡ ꯑꯁꯤ ꯁꯤꯖꯤꯟꯅꯩ꯫

ꯇꯤꯀꯥ ꯊꯥꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ, ꯅꯍꯥꯛꯅꯥ ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯟ ꯑꯃꯠꯇꯥ ꯂꯩꯕ꯭ꯔꯥ ꯍꯥꯌꯕꯗꯨ ꯌꯦꯡꯅꯕꯒꯤꯗꯃꯛ ꯆꯥꯎꯔꯥꯛꯅꯥ ꯄꯨꯡ ꯑꯃꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯂꯩꯕꯥ ꯃꯊꯧ ꯇꯥꯏ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯃꯁꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯝ ꯑꯃꯅꯥ ꯑꯦꯗꯃꯤꯅꯤꯁ꯭ꯠꯔꯦꯠ ꯇꯧꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯁꯤ ꯊꯣꯀꯄꯒꯤ ꯆꯥꯡ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯅꯦꯝꯃꯤ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯁꯤ ꯃꯑꯣꯡ ꯑꯃꯗꯥ ꯊꯣꯀꯈꯤꯕꯅꯤ ꯍꯥꯌꯅꯥ ꯆꯤꯡꯅꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU) ꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯕꯤꯌꯨ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯊꯧ ꯇꯥꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯗꯁꯨ ꯐꯣꯟ ꯇꯧꯕꯥ ꯌꯥꯏ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤꯗꯃꯛꯇꯥ ꯔꯤꯄꯤꯠ ꯗꯣꯖ ꯑꯃꯥ ꯂꯦꯄꯈ꯭ꯔꯕꯗꯤ, ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇ ꯑꯗꯨꯗꯥ ꯌꯥꯎꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯑꯃꯍꯦꯛꯇꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯁꯔꯨꯛ ꯌꯥꯕꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯃꯒꯥ ꯄꯥꯎ ꯐꯥꯎꯅꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯔꯤꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯕꯤꯌꯨ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯀꯔꯤꯅꯣ?

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ, ꯃꯁꯤꯅꯥ ꯃꯤꯑꯣꯏ ꯈꯔꯗꯗꯤ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯈꯣꯌ ꯈꯔꯗꯤ ꯌꯥꯝꯅꯥ ꯂꯨꯕꯥ ꯑꯣꯏꯕꯥ ꯌꯥꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯈꯣꯌꯗꯨ ꯈꯪꯖꯤꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔ ꯅꯠꯠꯔꯒꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯗꯤꯄꯥꯔꯇꯃꯦꯟꯇ (ETU)ꯗꯥ ꯈꯨꯗꯛꯇꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫
ꯁꯥꯊꯤꯕꯥ ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯅꯥ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯃꯤꯠ, ꯖꯤꯕ ꯅꯠꯠꯔꯒꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫
ꯍꯥꯔꯠ ꯑꯦꯇꯦꯛ ꯑꯃꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯈꯣꯡ, ꯈꯨꯎ, ꯃꯈꯨꯠ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯡꯗꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯅꯠꯠꯔꯒꯥ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯁꯣꯀꯄꯥ, ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ ꯅꯠꯠꯔꯒꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ꯫
ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡ, ꯈꯣꯡ ꯅꯠꯠꯔꯒꯥ ꯈꯨꯠꯁꯥꯁꯤꯡ ꯁꯣꯟꯊꯕꯥ, ꯈꯪꯍꯧꯗꯅꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ, ꯑꯆꯝꯕꯥ ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ꯫
ꯍꯥꯔꯠ ꯔꯦꯇꯇꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ꯫ ꯅꯍꯥꯛꯀꯤ ꯊꯝꯃꯣꯌꯅꯥ ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯁꯣꯀꯄꯥ, ꯃꯃꯤꯠ ꯇꯥꯡꯕꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯁꯣꯀꯄꯥ, ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ꯫
ꯃꯍꯧꯁꯥꯅꯥ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ, ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌ ꯑꯁꯤ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯅꯤ꯫
ꯀꯣꯛ ꯆꯤꯛꯄ ꯃꯌꯥꯏ ꯑꯣꯏꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯃꯌꯥꯏ ꯑꯣꯏꯕꯥ ꯍꯦꯗ-ꯑꯦꯛ꯫
ꯋꯥꯈꯜ ꯋꯥꯕꯥ / ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ꯫ ꯑꯆꯝꯕꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ꯫
ꯂꯣꯛ ꯈꯨꯕ ꯑꯅꯧꯕꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫
ꯏꯅꯖꯦꯀꯁꯟ ꯇꯧꯔꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯑꯁꯣꯛ-ꯑꯄꯟ ꯊꯣꯀꯄꯥ꯫ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯗꯨ ꯄꯤꯈꯤꯕꯥ ꯃꯐꯝ ꯑꯗꯨꯗꯥ ꯑꯅꯥꯕꯥ, ꯂꯥꯎꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯁꯣꯀꯄꯥ꯫

ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯄꯨꯝꯅꯃꯛ ꯌꯥꯎꯗꯦ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯁꯤꯒꯤ ꯃꯊꯛꯇꯥ ꯑꯆꯝꯕꯥ ꯂꯥꯏꯑꯣꯡ ꯑꯃꯠꯇꯥ ꯊꯦꯡꯅꯔꯕꯗꯤ, ꯆꯥꯅꯕꯤꯗꯨꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯏꯚꯨꯁꯦꯜꯗ (Tixagevimab; Cilgavimab) ꯑꯁꯤ ꯀꯣꯕꯤꯗ-꯱꯹ ꯉꯥꯀꯊꯣꯛꯅꯕꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ, ꯂꯥꯌꯅꯥ ꯑꯁꯤ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯅꯠꯇꯦ꯫
  • ꯃꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯏꯝꯝꯌꯨꯟ ꯁꯤꯁ꯭ꯇꯦꯝ ꯁꯣꯟꯊꯔꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯒꯤ ꯇꯤꯀꯥ ꯂꯧꯕꯥ ꯉꯃꯗꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ ꯄꯤꯔꯤ꯫
  • ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯅꯠꯠꯔꯒꯥ ꯀ꯭ꯂꯤꯅꯤꯛ ꯑꯃꯗꯥ ꯏꯅꯖꯦꯀꯁꯟ ꯑꯅꯤ ꯑꯣꯏꯅꯥ ꯄꯤ꯫
  • ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯂꯧꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯀꯟꯗꯤꯁꯟ ꯄꯨꯝꯅꯃꯛ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ ꯑꯃꯁꯨꯡ ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯆꯦꯛꯁꯤꯟ-ꯊꯧꯔꯥꯡꯁꯤꯡ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯃꯔꯃꯗꯤ ꯃꯁꯤ ꯑꯈꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ, ꯃꯇꯝ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯈꯛꯇꯗꯥ ꯊꯕꯛ ꯇꯧ꯫
❓ FAQ

FAQ

Evidence-based clinical answers to common patient questions

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯃꯁꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯝ ꯑꯃꯅꯥ ꯑꯦꯗꯃꯤꯅꯤꯁ꯭ꯠꯔꯦꯠ ꯇꯧꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯁꯤ ꯊꯣꯀꯄꯒꯤ ꯆꯥꯡ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯅꯦꯝꯃꯤ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯁꯤ ꯃꯑꯣꯡ ꯑꯃꯗꯥ ꯊꯣꯀꯈꯤꯕꯅꯤ ꯍꯥꯌꯅꯥ ꯆꯤꯡꯅꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU) ꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯕꯤꯌꯨ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯊꯧ ꯇꯥꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯗꯁꯨ ꯐꯣꯟ ꯇꯧꯕꯥ ꯌꯥꯏ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯩꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯅꯤ?

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯛꯀꯤꯗꯃꯛꯇꯥ ꯔꯤꯄꯤꯠ ꯗꯣꯖ ꯑꯃꯥ ꯂꯦꯄꯈ꯭ꯔꯕꯗꯤ, ꯑꯦꯄꯣꯏꯟꯇꯃꯦꯟꯇ ꯑꯗꯨꯗꯥ ꯌꯥꯎꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯔꯝ ꯑꯃꯍꯦꯛꯇꯗꯒꯤ ꯅꯍꯥꯛꯅꯥ ꯁꯔꯨꯛ ꯌꯥꯕꯥ ꯉꯃꯗ꯭ꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯇꯤꯃꯒꯥ ꯄꯥꯎ ꯐꯥꯎꯅꯕꯤꯌꯨ ꯑꯃꯁꯨꯡ ꯔꯤꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯕꯤꯌꯨ꯫

🔍 Search Keywords: tixagevimab cilgavimab solutions for injection • tixagevimab cilgavimab solutions for injection symptoms • tixagevimab cilgavimab solutions for injection causes and treatment • tixagevimab cilgavimab solutions for injection sri lanka • ꯗ꯭ꯔꯒ ꯏꯚꯨꯁꯦꯜꯗ (ꯇꯤꯛꯁꯥꯒꯦꯚꯤꯃꯦꯕ; ꯁꯤꯂꯒꯥꯚꯤꯃꯦꯕ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯉꯂꯁꯤ? ꯃꯁꯤꯅꯥ ꯀꯣꯕꯤꯗ-꯱꯹ꯗꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯗꯥ ꯃꯇꯦꯡ ꯑꯣꯏꯔꯤꯕꯔꯥ?

🩺 Articles For You

ꯅꯍꯥꯛ ꯑꯁꯤꯁꯨ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯀꯣꯜꯗ ꯑꯃꯁꯨꯡ ꯁꯥꯏꯅꯣꯁꯥꯏꯇꯤꯁ (Acute Sinusitis) ꯅꯥꯔꯀꯄꯔꯥ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ!

ꯅꯍꯥꯀꯁꯨ ꯐ꯭ꯂꯨ ꯅꯥꯔꯀꯄꯔꯥ? (ꯏꯅꯐ꯭ꯂꯨꯑꯦꯟꯖꯥ) ꯑꯀꯛꯅꯕꯥ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯑꯗꯨ ꯈꯪꯖꯤꯅꯁꯤ!

ꯅꯍꯥꯛꯅꯥ ꯐ꯭ꯂꯨ ꯂꯩꯕ꯭ꯔꯥ? ꯐ꯭ꯂꯨ ꯃꯈꯂꯁꯤꯡ ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ! (ꯐ꯭ꯂꯨꯒꯤ ꯃꯈꯂꯁꯤꯡ)

ꯀꯣꯜꯗ ꯑꯃꯁꯨꯡ ꯐ꯭ꯂꯨꯗꯒꯤ ꯀꯔꯝꯅꯥ ꯁꯥꯐꯅꯥ ꯂꯩꯒꯗꯒꯦ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ!

ꯀꯣꯜꯗ ꯑꯃꯁꯨꯡ ꯐ꯭ꯂꯨꯗꯒꯤ ꯀꯔꯝꯅꯥ ꯉꯥꯀꯊꯣꯛꯀꯗꯒꯦ? ꯃꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ!

ꯑꯦꯚꯤꯌꯟ ꯏꯅꯐ꯭ꯂꯨꯑꯦꯟꯖꯥꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯉꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ!

💬 Patient Questions & Comments (0)

Have a question or experience to share? Post a comment or reply to other readers below.

🛡️ Plain Text Only • No Links
👤

No comments yet. Be the first to share your question or experience below.

⚠️ Important: Medical articles and information on Nirogi Lanka are strictly for educational and awareness purposes and do not substitute professional medical advice, diagnosis, or treatment. Always consult a qualified physician for any medical concerns.